SCHEMBL4957015

SCHEMBL4957015

O=c1c2ccccc2nc(-c2ccccc2)n1-c1ccc(N2CCOCC2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.62
MEN1 O00255 2/20 0.62
KMT2A Q03164 2/20 0.62
HSP90AA1 P07900 1/20 0.62
ALDH1A1 P00352 10/20 0.59
TSHR P16473 1/20 0.59
SMN1; SMN2 Q16637 1/20 0.59
AKT1 P31749 2/20 0.59
TDO2 P48775 1/20 0.57
IDO2 Q6ZQW0 1/20 0.57
GAA P10253 2/20 0.56
KCNH2 Q12809 1/20 0.55
HRH3 Q9Y5N1 1/20 0.55
RAB9A P51151 2/20 0.55
NPSR1 Q6W5P4 1/20 0.55
KDM4E B2RXH2 2/20 0.54
HTT P42858 1/20 0.54
AHR P35869 1/20 0.54
HPGD P15428 1/20 0.54
MAPK1 P28482 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14571460 0.83 KMT2A (0.80) MAPTMEN1KMT2AHSP90AA1ALDH1A1
SCHEMBL28324629 0.81 ALDH1A1 (0.84) MAPTMEN1KMT2AHSP90AA1ALDH1A1
SCHEMBL2562269 0.81 JUN (0.51) MAPTALDH1A1TSHRSMN1; SMN2TDO2
SCHEMBL17643209 0.80 MEN1 (0.80) MAPTMEN1KMT2AHSP90AA1ALDH1A1
SCHEMBL31277320 0.80 KMT2A (0.70) MAPTMEN1KMT2AHSP90AA1ALDH1A1
SCHEMBL17643387 0.80 KMT2A (0.74) MAPTMEN1KMT2AHSP90AA1ALDH1A1
SCHEMBL17643007 0.80 MEN1 (0.70) MAPTMEN1KMT2AHSP90AA1ALDH1A1
SCHEMBL21658322 0.80 KMT2A (0.70) MAPTMEN1KMT2AHSP90AA1ALDH1A1
SCHEMBL17643389 0.80 ESR1 (0.71) MAPTMEN1KMT2AHSP90AA1ALDH1A1
SCHEMBL4397863 0.79 JUN (0.75) MAPTMEN1KMT2AHSP90AA1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008094909-A2 QUINAZOLINONE AND FUSED PYRIMIDINONE COMPOUNDS AND THEIR USE IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2008-08-07 WO claimed
WO-2008094909-A2 QUINAZOLINONE AND FUSED PYRIMIDINONE COMPOUNDS AND THEIR USE IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2008-08-07 WO disclosed
WO-2008094909-A2 QUINAZOLINONE AND FUSED PYRIMIDINONE COMPOUNDS AND THEIR USE IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2008-08-07 WO disclosed